Financial News · Live Terminal

Page 155 of 377

Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

The US Supreme Court on Monday denied petitions for writs of certiorari filed by six big pharmaceutical companies seeking to challenge the legality of the so-called 'Drug Price Negotiation Program' under the Inflation Reduction Act of 2022.AstraZeneca (AZN), Novartis (NVS), Novo Nordisk (NVO), Johnson & Johnson's (JNJ) Janssen Pharmaceuticals, Bristol Myers Squibb (BMY) and Boehringer Ingelheim Pharmaceuticals all had their petitions denied by the Supreme Court.The companies did not immediately respond to requests for comment from.Price: $183.25, Change: $+1.67, Percent Change: +0.92%

$AZN$BMY$JNJ$NVO$NVS

Wire46d ago

Yext Launching Digital Marketing Product Scout to Partners

Yext (YEXT) said Monday its Scout MCP and Scout API products are available to its partners to support digital marketing projects.The company said that Scout, a visibility intelligence product for local businesses, analyzes 10 billion signals monthly in four AI models for over 12 million business locations and delivers 150 visibility metrics for 20 competitors in each scan.Scout MCP will provide conversational access, and Scout API is for custom, white-labeled products, the company said.Price: $3.58, Change: $+0.12, Percent Change: +3.47%

$YEXT

Wire46d ago

Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

$AZN$BMY$JNJ$NVO$NVS

Wire46d ago

International Paper Buys Delmarva Corrugated Packaging Facility in Delaware

International Paper (IP) said Monday it has acquired Delmarva Corrugated Packaging's converting facility in Dover, Delaware.Financial details weren't disclosed.The acquisition is expected to enhance its manufacturing capabilities and increase its capacity to produce corrugated packaging products for customers, the company said.Price: $30.91, Change: $+0.65, Percent Change: +2.15%

$IP

Wire46d ago

Kimco Realty Sued by Coffee Drip Over Allegations of Fraudulent Business Practices

Kimco Realty (KIM) is being sued by Drip Coffee, which accuses the developer of open-air shopping centers of "systemic fraudulent business practices," the coffee brand said Monday.Drip Coffee alleged Kimco Realty signs multi-year leases with tenants while simultaneously planning to evict those tenants at a later date to make room for larger retailers.The lawsuit alleges Drip Coffee was used as a "pawn" to provide short-term rent to Kimco, while it was planning a redevelopment and demolition project of more than 100,000 square feet of the shopping center. Drip Coffee alleges Kimco committed fraud by soliciting leases they knew they could not fulfill."Kimco business practices have the company enter into agreements the company has no intention of keeping," Drip Coffee president Taylor Schear said. "Their practices are driven by greed despite the businesses and jobs destroyed, and the loss of the revenue and investments for the businesses that enter into contracts with Kimco in good faith."Kimco Realty didn't immediately respond to a request for comment from.Price: $23.41, Change: $+0.41, Percent Change: +1.78%

$KIM

Wire46d ago

UnitedHealth Group Shares Drop After Berkshire Sell Stake in Health Firm

UnitedHealth Group (UNH) shares fell 2.2% in early trading on Monday after Berkshire Hathaway (BRK.A, BRK.B) disclosed in a regulatory filing on Friday that it had sold all of its stake in the healthcare company.In August 2025, Berkshire had acquired about 5 million shares UnitedHealth.Trading volume stood at over 9.6 million against a daily average of around 8.5 million.Price: $386.30, Change: $-7.53, Percent Change: -1.91%

$BRK.A$BRK.B$UNH

Wire46d ago

Update: Brady Shares Rise After Higher Fiscal Q3 Results, 2026 Adjusted EPS Outlook

(Updates to include Brady's stock price movement in the headline and first paragraph.)Brady (BRC) shares were nearly 13% higher in early Monday trading after the company reported higher fiscal Q3 results and fiscal 2026 adjusted EPS guidance.The company reported fiscal Q3 adjusted earnings of $1.50 per diluted share, up from $1.22 a year earlier.Two analysts polled by FactSet expected $1.35.Net sales for the quarter ended April 30 were $435.2 million, compared with $382.6 million a year earlier.Two analysts polled by FactSet expected $406.1 million.For fiscal 2026, the company raised its adjusted diluted EPS outlook to between $5.20 and $5.30, from the previous range of $4.95 to $5.15. Two analysts polled by FactSet expect $5.01.Price: $80.13, Change: $+9.17, Percent Change: +12.92%

$BRC

Wire46d ago

BioMarin Pharmaceutical Reports No Functional Improvement in BMN 401 ENPP1 Deficiency Study

BioMarin Pharmaceutical's (BMRN) Phase 3 ENERGY 3 trial of BMN 401 in children with ENPP1 deficiency met one of two co-primary endpoints but did not show improvement in key clinical outcomes, the company said Monday.The study showed a statistically significant increase in plasma inorganic pyrophosphate levels but did not improve Radiographic Global Impression of Change scores, the primary measure of rickets severity.The company added that no notable trends were observed in secondary endpoints, and the therapy was generally well tolerated with no new safety concerns reported.Shares of BioMarin Pharmaceutical were down over 1% in Monday trading.Price: $51.27, Change: $-0.55, Percent Change: -1.05%

$BMRN

Wire46d ago

RTX's Raytheon Unit Completes Design Review of NASA's Landsat Next Space Instruments

RTX's (RTX) Raytheon business said Monday it has completed the preliminary design review for NASA's Landsat Next Instrument Suite, with the first sensor expected to be delivered in 2028.The design review validated the technical approach and engineering design of Raytheon's instruments, algorithms and imager, Raytheon said.The company provides the multispectral imager, engineering analyses, testing and support for the program, according to a statement.Price: $171.56, Change: $+0.47, Percent Change: +0.27%

$RTX

Wire46d ago

Citic Securities Adjusts Price Target on Applied Materials to $525 From $200, Maintains Buy Rating

Applied Materials (AMAT) has an average rating of buy and mean price target of $514.34, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $419.91, Change: $-16.71, Percent Change: -3.83%

$AMAT

Wire46d ago

BofA Securities Lifts Price Target on Klarna to $23 From $21, Maintains Buy Rating

Klarna (KLAR) has an average rating of overweight and mean price target of $21.44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $15.14, Change: $-0.04, Percent Change: -0.26%

$KLAR

Wire46d ago

Coursera Shares Rise After Launching $500 Million Stock Buyback Program

Coursera (COUR) shares were up 5% in early Monday trading after the online learning platform said its board has approved a share repurchase program of up to $500 million.Price: $5.54, Change: $+0.27, Percent Change: +5.02%

$COUR

Wire46d ago

JAKKS Pacific Renews Role-Play Toys Partnership With Stanley Black & Decker

JAKKS Pacific (JAKK) said Monday it extended its licensing agreement with Stanley Black & Decker (SWK) for its BLACK+DECKER-branded toy products through 2028.Financial terms were not provided.The agreement covers role-play toy products in the US, Canada, Mexico, and Colombia, the company said.JAKKS Pacific said the renewal also expands the partnership into additional product categories and retail channels.Price: $21.47, Change: $+0.15, Percent Change: +0.70%

$JAKK$SWK

Wire46d ago

Aaon Keeps Quarterly Dividend at $0.10 per Share, Payable June 26 to Shareholders of Record on June 5

$AAON

Wire46d ago

Onto Innovation Plans $1.1 Billion Convertible Notes Offering

Onto Innovation (ONTO) plans to offer $1.1 billion of convertible senior notes due 2031 in a private placement, the company said Monday.Initial purchasers will be granted an option to buy an additional $165 million of notes.Proceeds will be used for capped call transactions, up to $300 million in share repurchases, and general corporate purposes, including potential financing related to its planned acquisition of a 27% stake in Rigaku, the company added.Shares of Onto Innovation were down 3.6% in Monday's premarket trading.

$ONTO

Wire46d ago

Design Therapeutics' DT-216P2 Shows Clinical Improvements in Friedreich Ataxia Trial; Shares Rise Pre-Bell

Design Therapeutics (DSGN) reported top-line data Monday from its phase 1/2 RESTORE-FA clinical trial evaluating DT-216P2 to treat Friedreich ataxia, a recessive neurodegenerative disorder.The biotech company said that after a four-week dosing window for 16 patients, the multi-dose cohort evaluation demonstrated dose-dependent increases in frataxin mRNA and frataxin protein.It also said the treatment was generally well-tolerated, with no serious adverse events reported and no treatment discontinuations.Design Therapeutics said that it will use the trial data to progress DT-216P2 into a registrational development track, with a formal regulatory update expected in Q4.Shares of the company were up close to 7% pre-bell.

$DSGN

Wire46d ago

Macy's Shares Soar Over 5% After Berkshire Hathaway Discloses Stake

Macy's (M) shares rose more than 5% in premarket trading on Monday after Berkshire Hathaway (BRK.A) (BRK.B) disclosed a roughly $55 million investment in the company, representing about 3 million shares, or nearly 1.1% of the retailer.The investment marks Berkshire's first public department store bet since Warren Buffett and Charlie Munger acquired Baltimore-based Hochschild Kohn in 1966.The move comes as Macy's pushes ahead with its "Bold New Chapter" turnaround plan, which includes closing around 150 underperforming stores by 2028 while focusing on higher-performing locations.

$BRK.A$BRK.B$M

Wire46d ago

Market Chatter: Mizuho Financial Says Potential Rakuten Bank Investment Still Under Review; Shares Fall Pre-Bell

Mizuho Financial (MFG) shares fell over 3% in Monday premarket trading after the Japanese lender said it had not made a final decision on an investment in Rakuten Bank, CNBC reported Sunday.The Japanese daily Yomiuri Shimbun had earlier reported the bank was planning to increase its investment in Rakuten Bank while exiting its stake in Rakuten Card.Mizuho Financial said it was evaluating options but stressed that no decision had been reached, according to the CNBC report.Mizuho Financial did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $8.37, Change: $-0.32, Percent Change: -3.68%

$MFG

Wire46d ago

Regeneron Fails to Meet Primary Endpoint in Phase 3 Skin Cancer Trial; Shares Down Pre-Bell

Regeneron Pharmaceuticals (REGN) said late Friday that two dose levels of fianlimab in combination with cemiplimab, evaluated as a first-line treatment in unresectable locally advanced or metastatic melanoma, failed to meet a primary endpoint in its phase 3 trial.The combination demonstrated a numeric 5.1-month improvement in median progression-free survival compared to pembrolizumab monotherapy, but did not reach statistical significance for the primary endpoint, Regeneron said.Regeneron said that detailed results from the trial will be presented at an upcoming medical meeting.A phase 3 head-to-head trial of the high-dose fianlimab combination compared with Opdualag is ongoing, the company added.Shares of the company were down more than 11% in Monday's premarket activity.Price: $616.00, Change: $-82.25, Percent Change: -11.78%

$REGN

Wire49d ago

Sector Update: Energy Stocks Gain Late Afternoon

Energy stocks were higher late Friday afternoon, with the NYSE Energy Sector Index rising 1.5% and the State Street Energy Select Sector SPDR ETF (XLE) climbing up 2%.The Philadelphia Oil Service Sector Index was decreasing 0.3%, and the Dow Jones US Utilities Index fell 2.2%.Front-month West Texas Intermediate crude oil gained 4.2% to $105.43 a barrel, and the global benchmark Brent crude contract was advancing 3.4% to $109.31 a barrel. Henry Hub natural gas futures rose 2.7% to $2.97 per 1 million BTU.In sector news, US Secretary of Energy Chris Wright told CNBC on Friday he expects China to increase oil imports from the US because the two nations are natural partners and because China relies heavily on imports from the Middle East that have mostly been cut off for weeks.In corporate news, ConocoPhillips (COP) shares rose 2.9% after Argus raised its price target to $136 from $128, while keeping its buy rating.Exxon Mobil (XOM) was found not liable by a Texas jury in a lawsuit accusing the oil major of misleading investors about its Canadian oil sands and Rocky Mountain gas operations, Reuters reported late Thursday. Shares gained 3%.BP (BP) plans to cut its pipeline gas trading team and focus on expanding its liquified natural gas trading, Reuters reported. Separately, BP is contemplating selling some natural gas assets in Egypt, Reuters reported. Shares rose 1.7%.Prairie Operating (PROP) shares fell 15% after it reported a Q1 loss late Thursday of $2.16 per diluted share, narrowing from a loss of $3.49 a year earlier. Four analysts polled by FactSet expected earnings of $0.15.

$BP$COP$PROP$XOM

Showing 3081-3100 of 7528